3-iodobenzylguanidine has been researched along with metaraminol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raffel, DM; Wieland, DM | 1 |
| Bier, D; Coenen, HH; Ermert, J; Oesterreich, G; Pissarek, M | 1 |
1 review(s) available for 3-iodobenzylguanidine and metaraminol
| Article | Year |
|---|---|
Assessment of cardiac sympathetic nerve integrity with positron emission tomography.
Topics: 3-Iodobenzylguanidine; Carbon Radioisotopes; Fluorine Radioisotopes; Heart; Humans; Metaraminol; Phenylephrine; Sympathetic Nervous System; Tomography, Emission-Computed | 2001 |
1 other study(ies) available for 3-iodobenzylguanidine and metaraminol
| Article | Year |
|---|---|
Relative uptake, metabolism, and beta-receptor binding of (1R,2S)-4-(18)F-fluorometaraminol and (123)I-MIBG in normotensive and spontaneously hypertensive rats.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Animals; Autoradiography; Cardiomyopathies; Heart; Hypertension; Iodine Radioisotopes; Iodocyanopindolol; Liver; Male; Metaraminol; Myocardium; Propranolol; Radiopharmaceuticals; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Spleen; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |